Gene Page: FAT2
Summary ?
GeneID | 2196 |
Symbol | FAT2 |
Synonyms | CDHF8|CDHR9|HFAT2|MEGF1 |
Description | FAT atypical cadherin 2 |
Reference | MIM:604269|HGNC:HGNC:3596|Ensembl:ENSG00000086570|HPRD:05041|Vega:OTTHUMG00000130126 |
Gene type | protein-coding |
Map location | 5q33.1 |
Pascal p-value | 0.402 |
Fetal beta | 0.117 |
eGene | Nucleus accumbens basal ganglia Myers' cis & trans |
Support | CompositeSet Darnell FMRP targets |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:GWASdb | Genome-wide Association Studies | GWASdb records for schizophrenia | |
CV:PGCnp | Genome-wide Association Study | GWAS | |
GSMA_I | Genome scan meta-analysis | Psr: 0.0032 | |
GSMA_IIE | Genome scan meta-analysis (European-ancestry samples) | Psr: 0.01718 | |
GSMA_IIA | Genome scan meta-analysis (All samples) | Psr: 0.00459 |
Section I. Genetics and epigenetics annotation
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
rs17392743 | chr1 | 54764240 | FAT2 | 2196 | 0.19 | trans | ||
rs4661202 | chr1 | 156572983 | FAT2 | 2196 | 0.14 | trans | ||
rs6687849 | chr1 | 175904808 | FAT2 | 2196 | 0.12 | trans | ||
rs2481653 | chr1 | 176044120 | FAT2 | 2196 | 0.08 | trans | ||
rs2502827 | chr1 | 176044216 | FAT2 | 2196 | 0.01 | trans | ||
rs12405921 | chr1 | 206695730 | FAT2 | 2196 | 0.01 | trans | ||
rs17572651 | chr1 | 218943612 | FAT2 | 2196 | 0.01 | trans | ||
rs16829545 | chr2 | 151977407 | FAT2 | 2196 | 1.667E-19 | trans | ||
rs16841750 | chr2 | 158288461 | FAT2 | 2196 | 0.01 | trans | ||
rs3747518 | chr2 | 163128724 | FAT2 | 2196 | 0.03 | trans | ||
rs3845734 | chr2 | 171125572 | FAT2 | 2196 | 1.247E-5 | trans | ||
rs7584986 | chr2 | 184111432 | FAT2 | 2196 | 1.751E-11 | trans | ||
rs16878852 | chr4 | 27115684 | FAT2 | 2196 | 0.19 | trans | ||
rs2183142 | chr4 | 159232695 | FAT2 | 2196 | 0 | trans | ||
rs1396222 | chr4 | 173279496 | FAT2 | 2196 | 0.13 | trans | ||
rs335980 | chr4 | 173329784 | FAT2 | 2196 | 0.07 | trans | ||
rs337984 | chr4 | 173411662 | FAT2 | 2196 | 0.07 | trans | ||
rs6821203 | chr4 | 189475342 | FAT2 | 2196 | 0.16 | trans | ||
rs3111196 | chr5 | 54402889 | FAT2 | 2196 | 0 | trans | ||
rs17762315 | chr5 | 76807576 | FAT2 | 2196 | 4.387E-6 | trans | ||
rs1380396 | chr5 | 100737044 | FAT2 | 2196 | 0.05 | trans | ||
rs6887062 | chr5 | 123850762 | FAT2 | 2196 | 0.04 | trans | ||
rs9461864 | chr6 | 33481468 | FAT2 | 2196 | 0.04 | trans | ||
rs2530313 | chr7 | 148112233 | FAT2 | 2196 | 0.17 | trans | ||
rs4263735 | chr8 | 77931285 | FAT2 | 2196 | 0.08 | trans | ||
rs3118341 | chr9 | 25185518 | FAT2 | 2196 | 0.04 | trans | ||
rs17158735 | chr10 | 2681063 | FAT2 | 2196 | 0.13 | trans | ||
rs2393316 | chr10 | 59333070 | FAT2 | 2196 | 0.05 | trans | ||
rs4980232 | chr10 | 124577756 | FAT2 | 2196 | 0.09 | trans | ||
rs12289208 | chr11 | 125224267 | FAT2 | 2196 | 0.11 | trans | ||
rs1526959 | chr12 | 79753789 | FAT2 | 2196 | 0.17 | trans | ||
rs16955618 | chr15 | 29937543 | FAT2 | 2196 | 9.358E-33 | trans | ||
rs2414599 | chr15 | 58851618 | FAT2 | 2196 | 0.17 | trans | ||
rs154554 | chr16 | 22689068 | FAT2 | 2196 | 0.09 | trans | ||
rs7210845 | chr17 | 54122025 | FAT2 | 2196 | 0.06 | trans | ||
rs11873184 | chr18 | 1584081 | FAT2 | 2196 | 0.09 | trans | ||
rs1041786 | chr21 | 22617710 | FAT2 | 2196 | 5.045E-5 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression during devlopment (BrainCloud)
Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
No co-expressed genes in brain regions
Section III. Gene Ontology annotation
Molecular function | GO term | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0005509 | calcium ion binding | IEA | - | |
GO:0005509 | calcium ion binding | NAS | - | |
GO:0005515 | protein binding | IEA | - | |
Biological process | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0007155 | cell adhesion | IEA | - | |
GO:0007156 | homophilic cell adhesion | IEA | - | |
GO:0008150 | biological_process | ND | - | |
Cellular component | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0005575 | cellular_component | ND | - | |
GO:0016020 | membrane | IEA | - | |
GO:0016021 | integral to membrane | IEA | - | |
GO:0005886 | plasma membrane | IEA | - |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
NAKAMURA TUMOR ZONE PERIPHERAL VS CENTRAL DN | 634 | 384 | All SZGR 2.0 genes in this pathway |
JAEGER METASTASIS DN | 258 | 141 | All SZGR 2.0 genes in this pathway |
ENK UV RESPONSE KERATINOCYTE DN | 485 | 334 | All SZGR 2.0 genes in this pathway |
SIMBULAN UV RESPONSE NORMAL DN | 33 | 27 | All SZGR 2.0 genes in this pathway |
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY DN | 382 | 224 | All SZGR 2.0 genes in this pathway |
ONDER CDH1 TARGETS 2 DN | 464 | 276 | All SZGR 2.0 genes in this pathway |
DAZARD RESPONSE TO UV NHEK DN | 318 | 220 | All SZGR 2.0 genes in this pathway |
DAZARD UV RESPONSE CLUSTER G6 | 153 | 112 | All SZGR 2.0 genes in this pathway |
ACEVEDO METHYLATED IN LIVER CANCER DN | 940 | 425 | All SZGR 2.0 genes in this pathway |
SMID BREAST CANCER BASAL UP | 648 | 398 | All SZGR 2.0 genes in this pathway |
YOSHIMURA MAPK8 TARGETS UP | 1305 | 895 | All SZGR 2.0 genes in this pathway |
WU APOPTOSIS BY CDKN1A VIA TP53 | 55 | 31 | All SZGR 2.0 genes in this pathway |
KOINUMA TARGETS OF SMAD2 OR SMAD3 | 824 | 528 | All SZGR 2.0 genes in this pathway |
PEDRIOLI MIR31 TARGETS DN | 418 | 245 | All SZGR 2.0 genes in this pathway |
ZWANG TRANSIENTLY UP BY 1ST EGF PULSE ONLY | 1839 | 928 | All SZGR 2.0 genes in this pathway |
Section VI. microRNA annotation
miRNA family | Target position | miRNA ID | miRNA seq | ||
---|---|---|---|---|---|
UTR start | UTR end | Match method | |||
miR-17-5p/20/93.mr/106/519.d | 885 | 891 | m8 | hsa-miR-17-5p | CAAAGUGCUUACAGUGCAGGUAGU |
hsa-miR-20abrain | UAAAGUGCUUAUAGUGCAGGUAG | ||||
hsa-miR-106a | AAAAGUGCUUACAGUGCAGGUAGC | ||||
hsa-miR-106bSZ | UAAAGUGCUGACAGUGCAGAU | ||||
hsa-miR-20bSZ | CAAAGUGCUCAUAGUGCAGGUAG | ||||
hsa-miR-519d | CAAAGUGCCUCCCUUUAGAGUGU | ||||
hsa-miR-17-5p | CAAAGUGCUUACAGUGCAGGUAGU | ||||
hsa-miR-20abrain | UAAAGUGCUUAUAGUGCAGGUAG | ||||
hsa-miR-106a | AAAAGUGCUUACAGUGCAGGUAGC | ||||
hsa-miR-106bSZ | UAAAGUGCUGACAGUGCAGAU | ||||
hsa-miR-20bSZ | CAAAGUGCUCAUAGUGCAGGUAG | ||||
hsa-miR-519d | CAAAGUGCCUCCCUUUAGAGUGU | ||||
miR-221/222 | 1164 | 1170 | m8 | hsa-miR-221brain | AGCUACAUUGUCUGCUGGGUUUC |
hsa-miR-222brain | AGCUACAUCUGGCUACUGGGUCUC | ||||
miR-377 | 1390 | 1396 | m8 | hsa-miR-377 | AUCACACAAAGGCAACUUUUGU |
- SZ: miRNAs which differentially expressed in brain cortex of schizophrenia patients comparing with control samples using microarray. Click here to see the list of SZ related miRNAs.
- Brain: miRNAs which are expressed in brain based on miRNA microarray expression studies. Click here to see the list of brain related miRNAs.